Cyclin-dependent kinase (CDK) inhibitors for hormone receptor-positive advanced breast cancer
- Syn, Nicholas Li Xun
- Wee, Ian
- Wong, Andrea Li Ann
- Goh, Robby R.M.
- Ow, Samuel Guan Wei
- Lambertini, Matteo
- Lee, Soo Chin
Publication date
January 2018
DOI Publisher
Wiley ISSN
1465-1858 Citation count (estimate)
1Abstract
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effects of cyclin-dependent kinase (CDK) 4/6 inhibitors in the treatment of patients with hormone receptor-positive advanced breast cancer.SCOPUS: ar.jinfo:eu-repo/semantics/publishe
Add to ORKG